Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.
Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.
复制标题
DOI:
10.1016/j.neurobiolaging.2014.02.012
复制
发表时间:
2014-08
影响因子:
4.2
通讯作者:
Bieberich E
中科院分区:
文献类型:
--
作者:
Dinkins MB;Dasgupta S;Wang G;Zhu G;Bieberich E
We present evidence here that exosomes stimulate aggregation of Aβ1-42 in vitro and in vivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia in vitro. Exosome secretion is prevented by inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40% reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation in vivo by preventing exosome secretion and identifies nSMase2 as potential drug target in AD by interfering with exosome secretion.
登录
查看更多内容
DOI:
10.1523/jneurosci.1243-10.2010
发表时间:
2010-09-22
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Jana A;Pahan K
通讯作者:
Pahan K
影响因子:
82.9
作者:
HAASS, C;LEMERE, CA;SELKOE, DJ
通讯作者:
SELKOE, DJ
DOI:
10.1073/pnas.1209414109
发表时间:
2012-07-31
影响因子:
11.1
作者:
Fabbri, Muller;Paone, Alessio;Croce, Carlo M.
通讯作者:
Croce, Carlo M.
影响因子:
6.5
作者:
Krishnamurthy, Karman;Dasgupta, Somsankar;Bieberich, Erhard
通讯作者:
Bieberich, Erhard
影响因子:
3.7
作者:
Khan S;Jutzy JM;Valenzuela MM;Turay D;Aspe JR;Ashok A;Mirshahidi S;Mercola D;Lilly MB;Wall NR
通讯作者:
Wall NR